Advances in Rehabilitation Offers Hope for Stroke Survivors
Nexstim has launched a multicenter double-blinded, randomized, and sham-controlled trial to determine the therapeutic effects of navigated rTMS (repetitive transcranial magnetic stimulation) for stroke rehabilitation. This new stroke therapy combines occupational therapy with nTMS (navigated transcranial magnetic stimulation). Initial results from the Contrastim study have opened the door to improving the quality of life for stroke survivors.
The study is looking at the combination of non-invasive navigated transcranial stimulation (nTMS) along with occupational therapy (OT) in post-stroke patients. Called the NICHE trial (Navigated Inhibitory rTMS in Contralesional Hemisphere Evaluation), this study will be conducted at twelve of the top rehabilitation sites in the United States.
Ranchos Los Amigos National Rehabilitation Institute
Rehabilitation Institute of Chicago
Spaulding Rehabilitation Hospital
Burke Rehabilitation Center
Ohio State University
University of Cincinnati
TIRR Memorial Hermann Hospital
Treatment consists of 20 minutes of pre-functional occupational therapy, 17 minutes of navigated TMS, followed by 60 minutes of upper-limb task oriented OT. Patients received treatment during 3 visits per week for 6 weeks, the standard in the US. Then returning for follow up visits at 1 week, 1 month, 3 months, and 6 months.
To qualify, a patient must:
- Be 18 years of age or older
- Have hand and arm weakness on one side because of a stroke
- The stroke must be because of a blockage (ischemic) or a bleed (hemorrhagic)
- The stroke must have taken place within 3 to 12 months prior to starting the study